174 related articles for article (PubMed ID: 19833415)
1. [Current treatment of rheumatoid arthritis].
Carli P; Landais C; Aletti M; Cournac JM; Poisnel E; Paris JF
Rev Med Interne; 2009 Dec; 30(12):1067-79. PubMed ID: 19833415
[TBL] [Abstract][Full Text] [Related]
2. Assessment and management of rheumatoid arthritis.
Haraoui B
J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
[TBL] [Abstract][Full Text] [Related]
3. Early rheumatoid arthritis -- is there a window of opportunity?
Cush JJ
J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
[TBL] [Abstract][Full Text] [Related]
4. Controversies in rheumatoid arthritis glucocorticoid therapy.
Ruyssen-Witrand A; Constantin A
Joint Bone Spine; 2018 Jul; 85(4):417-422. PubMed ID: 29246530
[TBL] [Abstract][Full Text] [Related]
5. Optimal use of non-biologic therapy in the treatment of rheumatoid arthritis.
Jacobs JW
Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv3-8. PubMed ID: 22513146
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
[TBL] [Abstract][Full Text] [Related]
7. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
Castrejón I; Gibson KA; Pincus T
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
[TBL] [Abstract][Full Text] [Related]
9. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
10. Early intervention in rheumatoid arthritis.
Vasanth LC; Paget SA
Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):9-10, 15-7. PubMed ID: 17694189
[No Abstract] [Full Text] [Related]
11. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
Wolfe F; Caplan L; Michaud K
J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
[No Abstract] [Full Text] [Related]
12. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.
Saevarsdottir S; Wallin H; Seddighzadeh M; Ernestam S; Geborek P; Petersson IF; Bratt J; van Vollenhoven RF;
Ann Rheum Dis; 2011 Mar; 70(3):469-75. PubMed ID: 21149498
[TBL] [Abstract][Full Text] [Related]
13. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial.
Hørslev-Petersen K; Hetland ML; Junker P; Pødenphant J; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Johansen JS; Østergaard M; Stengaard-Pedersen K;
Ann Rheum Dis; 2014 Apr; 73(4):654-61. PubMed ID: 23434570
[TBL] [Abstract][Full Text] [Related]
14. [Current therapeutic strategy for rheumatoid arthritis].
Wollenhaupt J; Alten R; Burkhardt H; Edelmann E; Gromnica-Ihle E; Krause A; Krüger K; Manger B; Lorenz H; Müller-Ladner U; Nüsslein H; Pott HG; Tony H; Schneider M
MMW Fortschr Med; 2006 Oct; 148(42):38-42; quiz 43. PubMed ID: 17621798
[TBL] [Abstract][Full Text] [Related]
15. Management of early rheumatoid arthritis.
Suresh E
J Assoc Physicians India; 2007 May; 55():355-62. PubMed ID: 17844697
[TBL] [Abstract][Full Text] [Related]
16. Modern treatment strategies in rheumatoid arthritis.
Hetland ML
Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years.
Bijlsma JW; Jacobs JW
Ann N Y Acad Sci; 2014 May; 1318():27-31. PubMed ID: 24641732
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological treatment of rheumatoid arthritis and its comorbidities].
Krüger K
Internist (Berl); 2018 Apr; 59(4):341-351. PubMed ID: 29508003
[TBL] [Abstract][Full Text] [Related]
19. [Update on Current Care Guidelines. Rheumatoid Arthritis (RA)].
Duodecim; 2015; 131(15):1409-10. PubMed ID: 26433976
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of rheumatoid polyarthritis: evolution of concepts and strategies].
Dubost JJ; Soubrier M; Sauvezie B
Rev Med Interne; 1999 Feb; 20(2):171-8. PubMed ID: 10227098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
